Cosmo Pharmaceuticals NV
SIX:COPN

Watchlist Manager
Cosmo Pharmaceuticals NV Logo
Cosmo Pharmaceuticals NV
SIX:COPN
Watchlist
Price: 62.8 CHF 1.45% Market Closed
Market Cap: 1B CHF
Have any thoughts about
Cosmo Pharmaceuticals NV?
Write Note

Income Statement

Earnings Waterfall
Cosmo Pharmaceuticals NV

Revenue
189.3m EUR
Cost of Revenue
-43.6m EUR
Gross Profit
145.7m EUR
Operating Expenses
-53.6m EUR
Operating Income
92.1m EUR
Other Expenses
-16.4m EUR
Net Income
75.7m EUR

Income Statement
Cosmo Pharmaceuticals NV

Rotate your device to view
Income Statement
Currency: EUR
Dec-2007 Jun-2008 Dec-2008 Jun-2009 Dec-2009 Jun-2010 Dec-2010 Jun-2011 Dec-2011 Jun-2012 Dec-2012 Jun-2013 Dec-2013 Jun-2014 Dec-2014 Jun-2015 Dec-2015 Jun-2016 Dec-2016 Jun-2017 Dec-2017 Jun-2018 Dec-2018 Jun-2019 Dec-2019 Jun-2020 Dec-2020 Jun-2021 Dec-2021 Jun-2022 Dec-2022 Jun-2023 Dec-2023 Jun-2024
Revenue
Revenue
22
N/A
24
+9%
34
+43%
36
+4%
27
-25%
28
+4%
32
+16%
34
+6%
34
-2%
58
+73%
60
+3%
45
-24%
56
+24%
71
+26%
80
+12%
59
-26%
61
+4%
72
+19%
68
-6%
68
+0%
67
-1%
72
+7%
66
-9%
50
-23%
62
+24%
67
+7%
61
-9%
63
+4%
65
+3%
78
+20%
102
+31%
104
+2%
97
-7%
189
+96%
Gross Profit
Cost of Revenue
(13)
(13)
(13)
(13)
(13)
(13)
(14)
(15)
(14)
(15)
(16)
(18)
(19)
(20)
(22)
(23)
(20)
(19)
(20)
(21)
(22)
(22)
(22)
(22)
(25)
(27)
(28)
(29)
(33)
(36)
(40)
(42)
(39)
(44)
Gross Profit
9
N/A
11
+21%
21
+98%
23
+9%
14
-39%
14
+4%
18
+23%
19
+10%
19
-2%
43
+125%
43
+1%
27
-37%
37
+36%
51
+38%
58
+13%
36
-38%
41
+13%
54
+33%
48
-11%
47
-2%
45
-3%
50
+11%
44
-13%
28
-36%
37
+33%
40
+7%
33
-17%
35
+5%
32
-8%
42
+30%
62
+48%
62
+1%
57
-8%
146
+154%
Operating Income
Operating Expenses
(9)
(9)
(10)
(9)
(9)
(10)
(13)
(13)
(10)
(13)
(17)
(19)
(24)
(30)
(36)
(52)
(46)
(23)
(23)
(43)
(55)
(63)
(60)
(57)
(50)
(37)
(30)
(31)
(21)
(23)
(34)
(35)
(45)
(54)
Selling, General & Administrative
(5)
(4)
(6)
(6)
(5)
(6)
(6)
(6)
(6)
(6)
(6)
(7)
(8)
(10)
(17)
(29)
(23)
(10)
(16)
(31)
(46)
(54)
(51)
(42)
(35)
(24)
(19)
(17)
(10)
(13)
(20)
(20)
(28)
(34)
Research & Development
(5)
(6)
(4)
(4)
(4)
(4)
(7)
(7)
(5)
(7)
(11)
(12)
(18)
(21)
(19)
(23)
(23)
(13)
(8)
(9)
(9)
(9)
(10)
(14)
(15)
(15)
(14)
(14)
(8)
(12)
(12)
(16)
(15)
(21)
Depreciation & Amortization
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(4)
0
(4)
0
(4)
0
Other Operating Expenses
1
0
0
0
0
(0)
0
0
1
1
0
0
1
1
0
0
0
0
1
(3)
0
0
1
(2)
1
2
2
1
1
2
2
1
1
2
Operating Income
(0)
N/A
2
N/A
11
+617%
14
+24%
4
-68%
5
+2%
5
+5%
7
+42%
9
+31%
30
+236%
27
-12%
8
-70%
13
+61%
21
+61%
22
+6%
(16)
N/A
(5)
+66%
30
N/A
25
-19%
4
-84%
(10)
N/A
(12)
-30%
(17)
-33%
(29)
-75%
(12)
+58%
3
N/A
3
-13%
4
+46%
11
+161%
19
+73%
28
+46%
27
-4%
12
-55%
92
+653%
Pre-Tax Income
Interest Income Expense
1
1
1
2
1
1
1
1
1
1
1
58
60
66
69
10
(2)
(5)
4
(2)
(23)
(19)
(0)
(5)
(9)
(11)
(14)
(11)
13
19
(3)
(8)
(4)
1
Non-Reccuring Items
0
0
0
0
0
0
0
0
0
0
0
0
0
0
17
276
256
(2)
(2)
(2)
(0)
0
0
0
0
4
4
0
0
0
0
0
0
0
Total Other Income
(0)
(0)
(1)
(1)
(0)
(1)
(1)
(1)
(1)
(0)
(0)
(0)
(1)
(1)
0
(0)
6
0
(0)
(2)
0
13
(0)
(0)
(0)
(0)
(0)
0
(0)
(1)
(0)
(0)
(0)
(0)
Pre-Tax Income
0
N/A
2
+1 238%
12
+443%
15
+26%
5
-64%
5
-8%
4
-9%
6
+46%
9
+40%
31
+238%
27
-12%
66
+145%
72
+9%
86
+20%
109
+26%
270
+148%
254
-6%
23
-91%
27
+19%
(1)
N/A
(32)
-3 594%
(18)
+43%
(17)
+5%
(35)
-99%
(21)
+39%
(4)
+81%
(7)
-73%
(6)
+10%
24
N/A
38
+57%
24
-35%
19
-22%
8
-60%
93
+1 118%
Net Income
Tax Provision
(0)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(8)
(8)
(2)
(3)
(4)
(36)
(36)
(6)
(7)
(8)
(3)
(0)
(5)
(1)
4
(3)
(3)
(1)
(4)
(2)
(2)
(7)
(8)
(6)
(17)
Income from Continuing Operations
0
1
9
12
4
4
4
6
8
23
19
64
69
82
73
234
248
16
19
(4)
(32)
(23)
(18)
(31)
(24)
(7)
(8)
(11)
22
35
18
11
1
76
Income to Minority Interest
0
0
0
0
0
0
0
0
(0)
(0)
0
0
0
0
(0)
0
0
0
0
0
0
0
0
0
0
0
0
0
(0)
(0)
(0)
(0)
(0)
(0)
Net Income (Common)
0
N/A
1
+700%
9
+880%
12
+30%
4
-67%
4
-8%
4
-4%
6
+53%
8
+38%
23
+199%
19
-15%
64
+231%
69
+7%
82
+20%
73
-11%
234
+219%
248
+6%
16
-93%
19
+19%
(4)
N/A
(32)
-819%
(23)
+29%
(18)
+22%
(31)
-72%
(24)
+21%
(7)
+72%
(8)
-17%
(11)
-35%
22
N/A
35
+63%
17
-51%
11
-37%
1
-89%
76
+6 496%
EPS (Diluted)
0
N/A
0.07
N/A
0.68
+871%
0.89
+31%
0.25
-72%
0.24
-4%
0.24
N/A
0.37
+54%
0.52
+41%
1.66
+219%
1.38
-17%
4.34
+214%
4.71
+9%
5.69
+21%
5.12
-10%
16.24
+217%
17.23
+6%
1.13
-93%
1.34
+19%
-0.24
N/A
-2.19
-813%
-1.53
+30%
-1.2
+22%
-2.09
-74%
-1.67
+20%
-0.46
+72%
-0.55
-20%
-0.74
-35%
1.28
N/A
2.13
+66%
1.05
-51%
0.67
-36%
0.07
-90%
4.7
+6 614%

See Also

Discover More